106 related articles for article (PubMed ID: 22237767)
1. Plasma vitamin C concentrations in patients on routine hemodialysis and its relationship to patients' morbidity and mortality.
Dashti-Khavidaki S; Talasaz AH; Tabeefar H; Hajimahmoodi M; Moghaddam G; Khalili H; Lessan-Pezeshki M; Jahanmardi A
Int J Vitam Nutr Res; 2011 Jul; 81(4):197-203. PubMed ID: 22237767
[TBL] [Abstract][Full Text] [Related]
2. Low total vitamin C plasma level is a risk factor for cardiovascular morbidity and mortality in hemodialysis patients.
Deicher R; Ziai F; Bieglmayer C; Schillinger M; Hörl WH
J Am Soc Nephrol; 2005 Jun; 16(6):1811-8. PubMed ID: 15814831
[TBL] [Abstract][Full Text] [Related]
3. Plasma ascorbic acid concentrations in prevalent patients with end-stage renal disease on hemodialysis.
Sirover WD; Liu Y; Logan A; Hunter K; Benz RL; Prasad D; Avila J; Venkatchalam T; Weisberg LS; Handelman GJ
J Ren Nutr; 2015 May; 25(3):292-300. PubMed ID: 25455040
[TBL] [Abstract][Full Text] [Related]
4. Vitamin A, E, B12, and folic acid in end-stage renal disease Tunisian patients: status and predictive value for overall mortality and cardiovascular events.
Fellah H; Feki M; Taieb SH; Hammami B; Boubaker K; Lacour B; Ben Abdallah T; Kaabachi N
Clin Lab; 2011; 57(11-12):939-46. PubMed ID: 22239025
[TBL] [Abstract][Full Text] [Related]
5. Long-term survival of patients with end-stage renal disease on maintenance hemodialysis: a multicenter study in Iran.
Beladi-Mousavi SS; Alemzadeh-Ansari MJ; Alemzadeh-Ansari MH; Beladi-Mousavi M
Iran J Kidney Dis; 2012 Nov; 6(6):452-6. PubMed ID: 23146984
[TBL] [Abstract][Full Text] [Related]
6. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A; Naderi AS
Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
[TBL] [Abstract][Full Text] [Related]
7. Soluble CD40 ligand is elevated in type 1 diabetic nephropathy but not predictive of mortality, cardiovascular events or kidney function.
Lajer M; Tarnow I; Michelson AD; Jorsal A; Frelinger AL; Parving HH; Rossing P; Tarnow L
Platelets; 2010; 21(7):525-32. PubMed ID: 20701458
[TBL] [Abstract][Full Text] [Related]
8. Homocysteine-lowering vitamin B treatment decreases cardiovascular events in hemodialysis patients.
Righetti M; Serbelloni P; Milani S; Ferrario G
Blood Purif; 2006; 24(4):379-86. PubMed ID: 16755160
[TBL] [Abstract][Full Text] [Related]
9. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of insulin resistance and its relationship between anemia, secondary hyperparathyroidism, inflammation, and cardiac parameters in chronic hemodialysis patients.
Sit D; Kadiroglu AK; Yilmaz ME; Kara IH; Isikoglu B
Ren Fail; 2005; 27(4):403-7. PubMed ID: 16060127
[TBL] [Abstract][Full Text] [Related]
11. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial.
Santoro A; Mancini E; Bolzani R; Boggi R; Cagnoli L; Francioso A; Fusaroli M; Piazza V; Rapanà R; Strippoli GF
Am J Kidney Dis; 2008 Sep; 52(3):507-18. PubMed ID: 18617304
[TBL] [Abstract][Full Text] [Related]
12. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients.
Noordzij M; Korevaar JC; Bos WJ; Boeschoten EW; Dekker FW; Bossuyt PM; Krediet RT
Nephrol Dial Transplant; 2006 Sep; 21(9):2513-20. PubMed ID: 16799173
[TBL] [Abstract][Full Text] [Related]
13. Is there impact of mortality prior hemodialysis therapy in peritoneal dialysis patients?
Koc Y; Unsal A; Basturk T; Sakaci T; Ahbap-Dal E; Sinangil-Arar A; Kose-Budak S; Kayabasi H
Nefrologia; 2012 May; 32(3):335-42. PubMed ID: 22508142
[TBL] [Abstract][Full Text] [Related]
14. Type 2 diabetes in patients with end-stage renal disease is not associated with further increased serum inflammatory parameters.
Bodlaj G; Berg J; Pichler R; Sailer T; Biesenbach G
J Nephrol; 2004; 17(1):112-7. PubMed ID: 15151267
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular complications in diabetic patients undergoing regular hemodialysis: a 5-year observational study.
Al-Thani H; Shabana A; Hussein A; Sadek A; Sharaf A; Koshy V; El-Menyar A
Angiology; 2015 Mar; 66(3):225-30. PubMed ID: 24576984
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin and cardiovascular outcomes among hemodialysis patients.
Abdallah E; Waked E; Nabil M; El-Bendary O
Kidney Blood Press Res; 2012; 35(4):247-53. PubMed ID: 22286012
[TBL] [Abstract][Full Text] [Related]
17. [Current peritoneal dialysis compared with haemodialysis: medium-term survival analysis of incident dialysis patients in the Canary Islands in recent years].
Rufino JM; García C; Vega N; Macía M; Hernández D; Rodríguez A; Maceira B; Lorenzo V
Nefrologia; 2011; 31(2):174-84. PubMed ID: 21461011
[TBL] [Abstract][Full Text] [Related]
18. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].
Portolés J; López-Gómez JM; Aljama P
Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D deficiency, mortality, and hospitalization in hemodialysis patients with or without protein-energy wasting.
Fiedler R; Dorligjav O; Seibert E; Ulrich C; Markau S; Girndt M
Nephron Clin Pract; 2011; 119(3):c220-6. PubMed ID: 21832848
[TBL] [Abstract][Full Text] [Related]
20. Low serum testosterone, arterial stiffness and mortality in male haemodialysis patients.
Kyriazis J; Tzanakis I; Stylianou K; Katsipi I; Moisiadis D; Papadaki A; Mavroeidi V; Kagia S; Karkavitsas N; Daphnis E
Nephrol Dial Transplant; 2011 Sep; 26(9):2971-7. PubMed ID: 21427069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
